Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncology
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, vol.140, no.1, pp.151-157, 2014 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 140 Issue: 1
- Publication Date: 2014
- Doi Number: 10.1007/s00432-013-1553-7
- Journal Name: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.151-157
- Keywords: Melanoma, Brain metastases, Predictive factors
- Dokuz Eylül University Affiliated: Yes
Abstract
The development of brain metastases (BMs) was associated with poor prognosis in melanoma patients. Patients with BMs have a median survival of < 6 months. Melanoma is the third most common tumor to metastasize to the brain with a reported incidence of 10-40 %. Our aim was to identify factors predicting development of BMs and survival.